7 Deep Analysis: The Meaning of Glucagon in Peptide Product Composition
Published: July 18, 2026 16:16
Author: Julia Clayton
Abstract: Glucagon’s role in peptide product composition extends beyond glucose regulation, serving as a critical stabilizer and bioavailability enhancer in GLP-1/GIP co-formulations. Market data (2024–2030 CAGR 8.9%) reveals a shift toward dual-agonist peptides, with leading brands (e.g., Novo Nordisk, Eli Lilly) demonstrating superior purity (>99%) via HPLC. Technical trade-offs include enhanced efficacy versus injection-site reactions. Comparative analysis of product parameters (half-life, receptor affinity) and factory certifications (GMP, ISO 13485) underpins selection criteria. Logistics require cold-chain integrity (2–8°C). Industry trends prioritize multi-target peptides, reshaping brand differentiation and regulatory compliance.